The sources we watch.
Continuously parsing official EU and national health policy sources via structured and unstructured feeds, normalized into one queryable index.
EU-wide
25 sourcesACT EU - Accelerating Clinical Trials
Clinical Trials Information System (CTIS)
EC AI Act & Regulation
EC Clinical Trials
EC Competition - Pharma Sector
EC Data Strategy
EC Digital Health
EC Medical Devices
EC Pharmaceutical Strategy
EC Public Health
EDQM - European Pharmacopoeia
European Pharmacopoeia standards and quality control
EMA - European Medicines Agency
Centralized drug authorizations and pharmacovigilance updates
EMA Regulatory Guidelines
Clinical trial protocols, GMP standards, and regulatory procedures
EU AI Act Implementation
EU HTA Regulation Implementation
EUDAMED
EUnetHTA 21
EUR-Lex Official Journal
EU directives, regulations, and implementing acts in healthcare
European Health Data Space
European Health Data Space
gematik (German Digital Health)
E-prescription standards, health card updates, and telematics infrastructure
Heads of Medicines Agencies
HTA Coordination Group
MyHealth@EU Cross-Border Services
Scottish Medicines Consortium
Belgium
2 sourcesFAMHP (Belgian Medicine Agency)
Belgian pharmaceutical oversight and clinical trial approvals
INAMI-RIZIV (Belgian HTA)
Denmark
1 sourceDanish Medicines Agency
France
6 sourcesANS - French Digital Health Agency
ANSM (French Medicine Agency)
French drug safety monitoring and clinical trial authorizations
CEPS - Drug Pricing Committee
CNIL - Health Data
French Ministry of Health
French healthcare system reforms and public health campaigns
Haute Autorité de Santé (HAS)
French drug reimbursement decisions and medical device evaluations
Germany
8 sourcesBfArM (Federal Institute for Drugs)
German drug approvals, clinical trial authorizations, and risk assessments
BfArM DiGA Fast Track
German drug approvals, clinical trial authorizations, and risk assessments
BSI - Healthcare Cybersecurity
DIMDI Medical Device Database
G-BA (Federal Joint Committee)
German benefit assessments and reimbursement decisions
German Federal Ministry of Health
IQWiG (German HTA)
Paul-Ehrlich-Institut
Vaccine approvals and blood product regulations in Germany
Italy
3 sourcesAgenas - Italian HTA
AIFA (Italian Medicines Agency)
Italian Ministry of Health
Netherlands
4 sourcesCBG-MEB (Dutch Medicine Agency)
Dutch medicine evaluations and pharmacovigilance activities
Dutch Ministry of Health
Dutch healthcare insurance updates and quality standards
RIVM - Dutch Health Institute
Dutch public health research and vaccination programs
Zorginstituut Nederland
Norway
1 sourceNoMA (Norwegian Medicines Agency)
Spain
3 sourcesAEMPS (Spanish Medicine Agency)
Spanish Health Technology Institute
Spanish Ministry of Health
Sweden
2 sourcesSwedish Medical Products Agency
TLV (Swedish HTA)
Switzerland
2 sourcesSwiss Federal Office of Public Health
Swissmedic
Swiss drug approvals and medical device certifications
United Kingdom
9 sourcesNHS Digital/England
NHS app updates, digital transformation, and data standards
NHS Transformation Directorate
Service changes, clinical guidelines, and commissioning policies
UK Care Quality Commission
UK DHSC
UK health policy statements, consultations, and impact assessments
UK Drug Safety Update
UK Health Research Authority
UK ICO - Health Sector
UK MHRA
UK pharmaceutical licensing and post-market surveillance
UK NICE
Cost-effectiveness assessments and clinical practice guidelines